PLN | Phospholamban | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
PLP2 | Proteolipid protein 2 (colonic epithelium-enriched) | Predicted membrane proteins Transporters
| | | | | Expressed in all |
PLTP | Phospholipid transfer protein | Plasma proteins Predicted intracellular proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
PON1 | Paraoxonase 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
PSAP | Prosaposin | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Expressed in all |
PSEN1 | Presenilin 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PSEN2 | Presenilin 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PXMP4 | Peroxisomal membrane protein 4, 24kDa | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
REG3A | Regenerating islet-derived 3 alpha | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
RHAG | Rh-associated glycoprotein | CD markers Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
RHBG | Rh family, B glycoprotein (gene/pseudogene) | Predicted membrane proteins Transporters
| | | | | Group enriched |
RHCG | Rh family, C glycoprotein | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
RYR1 | Ryanodine receptor 1 (skeletal) | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
RYR2 | Ryanodine receptor 2 (cardiac) | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SAMM50 | SAMM50 sorting and assembly machinery component | Mitochondrial proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
SCN11A | Sodium channel, voltage-gated, type XI, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
SCN2A | Sodium channel, voltage-gated, type II, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
SCN4A | Sodium channel, voltage-gated, type IV, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
SCN9A | Sodium channel, voltage-gated, type IX, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
SCNN1A | Sodium channel, non-voltage-gated 1 alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SCNN1B | Sodium channel, non-voltage-gated 1, beta subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SIDT1 | SID1 transmembrane family, member 1 | Predicted membrane proteins Transporters
| | | | | Mixed |
SIDT2 | SID1 transmembrane family, member 2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC14A1 | Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | Blood group antigen proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC31A1 | Solute carrier family 31 (copper transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC31A2 | Solute carrier family 31 (copper transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC41A1 | Solute carrier family 41 (magnesium transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC41A2 | Solute carrier family 41 (magnesium transporter), member 2 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
SLC41A3 | Solute carrier family 41, member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SNAP23 | Synaptosomal-associated protein, 23kDa | Predicted intracellular proteins Transporters
| | | | | Expressed in all |
SNAP25 | Synaptosomal-associated protein, 25kDa | FDA approved drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
SNAPIN | SNAP-associated protein | Predicted intracellular proteins Transporters
| | | | | Expressed in all |
SNCA | Synuclein, alpha (non A4 component of amyloid precursor) | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
SPPL2A | Signal peptide peptidase like 2A | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
STATH | Statherin | Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
STIM1 | Stromal interaction molecule 1 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
STX1A | Syntaxin 1A (brain) | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
STX4 | Syntaxin 4 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SYT1 | Synaptotagmin I | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
TMBIM6 | Transmembrane BAX inhibitor motif containing 6 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
TMC6 | Transmembrane channel-like 6 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
TMC8 | Transmembrane channel-like 8 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM63B | Transmembrane protein 63B | Predicted membrane proteins Transporters
| | | | | Expressed in all |
TNFAIP2 | Tumor necrosis factor, alpha-induced protein 2 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
TOMM40 | Translocase of outer mitochondrial membrane 40 homolog (yeast) | Mitochondrial proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
TP53 | Tumor protein p53 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transcription factors Transporters
| | | | | Expressed in all |
TPCN1 | Two pore segment channel 1 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Expressed in all |
TPCN2 | Two pore segment channel 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Expressed in all |
TRIM72 | Tripartite motif containing 72, E3 ubiquitin protein ligase | Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
TRPA1 | Transient receptor potential cation channel, subfamily A, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |